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AbstrAct
Objective To assess temporal trends of in-hospital 
mortality in patients with acute myocardial infarction (AMI) 
enrolled in the Swiss nationwide registry (AMIS Plus) 
over the last 20 years with regard to gender, age and in-
hospital treatment.
Methods All patients with AMI from 1997 to 2016 were 
stratified according to ST-segment elevation myocardial 
infarction (STEMI) or non-STEMI (NSTEMI), and gender 
using logistic regression analyses.
Results Among 51 725 patients, 30 398 (59%) had 
STEMI and 21 327 (41%) had NSTEMI; 73% were men 
(63.9±12.8 years) and 27% were women (71.7±12.5 
years). Over 20 years, crude in-hospital STEMI mortality 
decreased from 9.8% to 5.5% in men and from 18.3% 
to 6.9% in women. In patients with NSTEMI, it decreased 
from 7.1% to 2.1% in men and from 11.0% to 3.6% in 
women. After adjustment for age, mortality decreased per 
additional admission year by 3% in men with STEMI (OR 
0.97, 95% CI 0.96 to 0.98, P<0.001), by 5% in women 
with STEMI (OR 0.95, 95% CI 0.93 to 0.96, P<0.001), by 
6% in men with NSTEMI (OR 0.94, 95% CI 0.93 to 0.96, 
P<0.001) and by 5% in women with NSTEMI (OR 0.95, 
95% CI 0.93 to 0.97, P<0.001). In patients <60 years, 
a decrease in mortality was seen in women with STEMI 
(OR 0.94, 95% CI 0.90 to 0.99, P=0.025) and NSTEMI (OR 
0.87, 95% CI 0.80 to 0.94, P<0.001) but not in men with 
STEMI (OR 1.01, 95% CI 0.98 to 1.04, P=0.46) and NSTEMI 
(OR 0.98, 95% CI 0.94 to 1.03, P=0.41). The mortality 
decrease in patients with AMI was closely associated with 
the increase in reperfusion therapy.
Conclusion From 1997 to 2016, in-hospital mortality of 
patients with AMI in Switzerland has halved and was more 
pronounced in women, particularly in the age category 
<60 years.
Trial registration number NCT01305785; Results.
InTROduCTIOn
Cardiovascular disease continues to be the 
leading cause of death in the Western world 
in both women and men. Administrative data 
showed that mortality of patients with acute 
myocardial infarction (AMI) considerably 
decreased worldwide between the 1970s and 
the beginning of the new millennium.1–7 
The lower risk of AMI in women cannot 
be explained by differences in established 
coronary heart disease risk factors.8 However, 
important differences in baseline character-
istics between male and female patients with 
AMI have been published in our previous 
studies.9–11 Further reports showed that 
younger women with acute coronary 
syndrome (ACS) had worse outcomes than 
men of the same age.7 12–15
Although women with AMI have a higher 
mortality than men, a prominent decline 
has occurred since 2000, which could be the 
result of the application of evidence-based 
therapies and education to improve aware-
ness of heart disease in women.16 Most of the 
published data only cover the time period 
up until 2008, and knowledge on mortality 
trends in hospital mortality of patients with 
AMI in Switzerland is sparse, revealing the 
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Key questions
What is already known about this subject?
Women with acute myocardial infarction (AMI) have 
higher in-hospital mortality. However, an overall 
decrease in mortality has been reported in studies 
using administrative databases.
What does this study add?
These contemporary clinical data reveal that the 
gender gap in AMI mortality has been reduced over 
the past two decades, particularly in young women. 
AMI therapy has undergone substantial changes. The 
mortality decrease could in large be explained by the 
increase in reperfusion therapy.
How might this impact on clinical practice?
These results are important for cardiovascular 
epidemiology and cardiologists. The trends in 
treatment and in-hospital mortality of patients with AMI 
in Switzerland are positive. Trends should be closely 
monitored in general to enable a timely reaction if 
needed, particularly for certain patient subgroups.
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need for a study that includes contemporary clinical data 
with a long-lasting observational period.
Therefore, the aims of this study were to assess gender 
differences in in-hospital mortality of patients with 
ST-segment elevation myocardial infarction (STEMI) and 
non-STEMI (NSTEMI) during the last 20 years in Switzer-
land and to evaluate these differences in patients below 
60 years of age.
MeTHOds
The AMIS Plus registry is an ongoing nationwide prospec-
tive cohort of patients admitted with ACS to hospitals in 
Switzerland, founded by the Swiss Societies of Cardiology, 
Internal Medicine and Intensive Care Medicine in 1997. 
Details of the registry have been described elsewhere.17–20 
Since 1997, 83 hospitals ranging from community insti-
tutions to large tertiary facilities temporarily or contin-
uously provide, on a voluntary basis, blinded data for 
each patient by the treating physician or a trained study 
nurse through standardised internet-based or paper-
based questionnaires. All data are checked for complete-
ness, plausibility and consistency by the AMIS Plus Data 
Center (Epidemiology, Biostatistics and Prevention Insti-
tute, University of Zurich, Switzerland). The data centre 
queries treating physicians or study nurses if data are 
incomplete, implausible or inconsistent. Since 2010, 
external monitoring is regularly performed in randomly 
selected hospitals using randomly selected cases.
Patient selection
The present study included all patients with a definitive 
diagnosis of AMI defined according to the universal defi-
nitions of myocardial infarction (MI) by characteristic 
symptoms and/or ECG changes and/or cardiac marker 
elevation (either creatine kinase MB fraction at least 
two times the upper limit of normal or troponin I or T 
above individual hospital cut-off levels for MI).21 Patients 
included in this analysis were categorised as having 
STEMI or NSTEMI based on the initial ECG findings. 
Classification of STEMI included evidence of AMI as 
described above and ST segment elevation and/or new 
left bundle branch block (LBBB) on the initial ECG. 
NSTEMI included patients with ischaemic symptoms, 
ST segment depression or T-wave abnormalities in the 
absence of ST elevation on the initial ECG. All patients 
with a definitive diagnosis of AMI were included regard-
less of age, delay, inpatient onset or therapy received, and 
only patients with unstable angina were excluded.
Reperfusion therapy included thrombolysis or percu-
taneous coronary intervention (PCI). Immediate drug 
therapy was defined if administrated within 24 hours after 
presentation and was prescribed according to current 
practice and guideline recommendations at the time of 
the index presentations. The choice of intervention and 
medication was at the discretion of the treating physi-
cians and hence reflects common practice in Switzerland.
statistical analyses
The results are presented as percentages for categorical 
variables and were analysed using the Pearson χ2 test or 
Fisher’s exact test as appropriate. Continuous normally 
distributed variables are expressed as means±1 SD and 
were compared using the Student’s two-tailed unpaired 
t-test. Continuous non-normally distributed variables are 
expressed as medians and IQRs and were analysed using 
the Mann-Whitney U test.
Univariable and multivariable binary logistic regres-
sions were used to analyse trends of mortality over admis-
sion years. The explanatory variables were gender, age and 
therapies. Admission year was included as a covariate. As 
the effect of age on mortality was non-linear, a quadratic 
dependence of age was used in multivariable regression. 
Model fit was assessed using the Hosmer-Lemeshow 
test. Adjusted ORs are reported with 95% CIs. The use 
of therapies changed non-linearly over time. Hence, 
gender differences in therapies were stratified by year of 
admission and analysed using the Mantel-Haenszel test. 
Interactions were assessed using the Breslow-Day test. A 
P value of less than 0.01 was considered significant. IBM 
SPSS Statistics software (V.23, IBM Corp. Armonk, NY, 
USA) was used for statistical analyses.
ResulTs
From January 1997 to December 2016, 51 725 patients 
with AMI from 83 Swiss hospitals were enrolled in the 
AMIS Plus registry and included in this study. Among 
them, 30 398 (59%) had STEMI and 21 327 (41%) had 
NSTEMI; 73% were men (mean age 63.9±12.8 years) and 
27% were women (71.7±12.5 years).
The probability of in-hospital mortality using logistic 
regression in patients with AMI aged 66 years according 
to admission year and gender is depicted in figure 1A,B.
sT-segment elevation myocardial infarction
Of the patients with STEMI, 26% were women aged 
71.3±12.7 years compared with men aged 62.8±12.8 
years (P<0.001). Over the study period, crude in-hos-
pital mortality decreased from 9.8% to 5.5% in men and 
from 18.3% to 6.9% in women (both P<0.001) (figure 2). 
The quadratic model of logistic regression for mortality 
of patients with STEMI demonstrated a significance for 
non-linearity of age of P<0.001. After adjustment for 
gender and age, early mortality reduction was 4% per 
additional admission year for all patients with STEMI 
(OR 0.96, 95% CI 0.95 to 0.97, P<0.001). There was a 
weak interaction between admission year and gender 
(P=0.019). Age-adjusted mortality decreased in men with 
STEMI at a rate of 3% (OR 0.97, 95% CI 0.96 to 0.98, 
P<0.001) and in STEMI women at a rate of 5% per addi-
tional admission year (OR 0.95, 95% CI 0.93 to 0.96, 
P<0.001).
non-sT-segment elevation myocardial infarction
Among patients with NSTEMI, 27% were women and 
were older than men (72.2±12.2 years vs 65.6±12.6 
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Figure 1 The predicted probability of in-hospital mortality in patients with AMI aged 66 years according to admission year and 
gender. STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction.
Figure 2 Crude in-hospital mortality of patients with STEMI 
according to admission year and gender from 1997 to 
2016. STEMI, ST-segment elevation myocardial infarction.
Figure 3 Crude in-hospital mortality of patients with 
NSTEMI according to admission year and gender from 1997 
to 2016. NSTEMI, non-ST-segment elevation myocardial 
infarction.
Coronary artery disease
years, P<0.001). From 1997 to 2016, crude in-hospital 
mortality decreased in men from 7.1% to 2.1% (P<0.001) 
and in women from 11.0% to 3.6% (P<0.001) (figure 3). 
The quadratic model of logistic regression for mortality 
of patients with NSTEMI also demonstrated a significance 
for non-linearity of age (P=0.001). After adjustment for 
gender and age, early mortality reduction was 6% for 
all patients with NSTEMI (OR 0.94, 95% CI 0.93 to 0.96, 
P<0.001) with no interaction between admission year and 
gender (P=0.75). The age-adjusted mortality decrease 
per additional admission year in patients with NSTEMI 
was even higher at 6% in men (OR 0.94, 95% CI 0.93 to 
0.96, P<0.001) and 5% in women (OR 0.95, 95% CI 0.93 
to 0.97, P<0.001).
Reperfusion
The use of reperfusion (thrombolysis or PCI) increased 
in male patients with STEMI from 60% to 93% (P<0.001) 
and in female patients with STEMI from 45% to 90% 
(P<0.001). Use of thrombolysis in patients with STEMI 
continuously decreased from 47% in 1997 down to 0.2% 
in 2016 (P<0.001), whereby the use of PCI increased from 
8.3% to 91.8% (P<0.001). This increase between 1997 
and 2016 was gender dependent (interaction between 
admission year and gender, P<0.001): in men from 9.1% 
to 92.5% (P<0.001) and in women from 6.0% to 89.5% 
(P<0.001).
The use of PCI increased in patients with NSTEMI from 
3.8% to 75.8% (P<0.001). This increase between 1997 and 
2016 was not gender dependent (interaction between 
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admission year and gender, P=0.42): in men from 4.7% 
to 76.5% (P<0.001) and in women from 1.4% to 74.5% 
(P<0.001).
The mortality decrease in patients with AMI could in 
large be explained by the increase in reperfusion therapy: 
after adjustment for reperfusion use, a reduction in 
mortality of 1% per year remained (OR 0.99, 95% CI 0.98 
to 1.00, P=0.007), whereas the gender difference disap-
peared (OR 0.99, 95% CI 0.90 to 1.09, P=0.85).
drug therapies
Throughout the entire observational period, women 
with AMI (STEMI and NSTEMI) were overall less likely 
to receive guideline-recommended drugs than men 
with AMI. Among women, 94.0% received aspirin versus 
95.6% of men (OR 0.72, 95% CI 0.66 to 0.78,  P<0.001) 
with no evidence of OR changes for gender over time 
(Breslow-Day P=0.80). Overall P2Y12 inhibitors (clopi-
dogrel, prasugrel or ticagrelor) were given to 63.8% of 
women compared with 72.3% of men (OR 0.61, 95% CI 
0.58 to 0.65, P<0.001) with significant OR changes during 
the observation period (Breslow-Day P=0.009). Statins 
were given to 69.2% of women compared with 76.5% 
of men (OR 0.69, 95% CI 0.66 to 0.73, P<0.001) with 
no OR changes over time (Breslow-Day P=0.24). Beta 
blockers were given to 61.4% of female patients with AMI 
versus 64.6% of male patients (OR 0.86, 95% CI 0.82 to 
0.90, P<0.001) with OR changes over time (Breslow-Day 
P<0.001) and angiotensin-converting enzyme inhibitors/
angiotensin II receptor antagonists to 49.3% of women 
versus 50.8% of men (OR 0.95, 95% CI 0.92 to 0.98, 
P=0.021) without significant OR changes during the 
observational years (Breslow-Day P=0.021).
Younger patients with AMI
In patients aged below 60 years, a decrease in early 
mortality per additional admission year of STEMI was seen 
in women (OR 0.94, 95% CI 0.90 to 0.99, P=0.025) but not 
in men (OR 1.01, 95% CI 0.98 to 1.04, P=0.46) (interac-
tion between gender and admission year P=0.019). Even 
greater differences were seen in patients with NSTEMI. 
Mortality per year dramatically decreased in NSTEMI 
women (OR 0.87, 95% CI 0.80 to 0.94, P<0.001) but was 
not significant in men (OR 0.98, 95% CI 0.94 to 1.03, 
P=0.41) (interaction between gender and admission year, 
P=0.006).
dIsCussIOn
The results of this study show that over the last 20 years, 
in-hospital mortality of patients with AMI in Switzer-
land has halved and the gender gap reduced. Although 
in-hospital mortality was consistently higher in women, 
overall age-adjusted mortality has decreased more prom-
inently in women compared with men. In this contem-
porary cohort of 51 725 patients, a reduction in mortality 
was seen in patients with STEMI and NSTEMI of both 
genders. However, in patients aged below 60 years, a 
significant decrease in in-hospital mortality was observed 
in women but not in men.
The gender differences in the baseline characteris-
tics of patients with AMI are well known and repeat-
edly described in the literature: women are older, have 
a higher burden of risk factors, have more comorbid-
ities and are less likely to receive evidence-based thera-
pies.16 22–25 Previously published works of ours have also 
shown this.9 26
However, gender differences in short-term and long-
term crude mortality of patients with AMI have been 
described in several studies with contradictory results. 
Studies mainly reported on gender differences in crude 
mortality, but the differences no longer existed if mortality 
was adjusted for age, risk factors or comorbidities.12 24 27 28 
Analyses of 78 254 patients from 2001 to 2006 in the ‘Get 
with the Guidelines’ database showed no differences in 
in-hospital mortality of all patients with AMI, but it was 
higher in women with STEMI.25 Women with ACS had 
worse in-hospital outcomes than men,22 and age-adjusted 
in-hospital mortality was higher for women.29 Analysis 
of temporal trends in in-hospital mortality of 916 380 
patients with AMI from 1994 to 2006 in the National 
Registry of Myocardial Infarction showed that women 
experienced larger improvements than men.30 This is in 
line with our current results.
AMI therapy has undergone substantial changes over 
the 20-year period, and the use of reperfusion therapies 
has continually increased away from thrombolysis towards 
PCI, but there was a significant underuse in women.9 10 31 
Although interventional strategies are equally effective in 
biomarker-positive men and women32 and the potential 
benefit on survival after 5 years appears to be similar in 
both genders, invasive therapy remains less frequently 
used in women than in men with AMI.33 In our study, 
PCI treatment continuously increased in both genders 
but was age dependent. Therefore, the age-adjusted 
mortality decrease in patients with AMI could in large 
be explained by the increase in reperfusion therapy with 
no differences between men and women. In a meta-anal-
ysis of 35 randomised controlled trials and observational 
studies of patients with STEMI who underwent PCI, the 
gender differences in short-term and long-term mortality 
remained significant even after adjustment.23 However, 
a study from the Mayo Clinic, which included 19 239 
patients who underwent PCI from 1979 to 2004, showed 
a decrease in mortality during this period with no differ-
ences between men and women.34
Younger women with AMI had a higher mortality than 
men of similar age.7 12–15 Our study showed that the 
decrease in in-hospital mortality of the patients below 
60 years was not significant in male patients but mark-
edly reduced in female patients over the last 20 years. A 
study on young patients with AMI (30 to 54 years) from 
the National Inpatients Sample database showed that 
in-hospital mortality decreased between 2001 and 2010 
in women although they had more comorbidities than 
young men.35 We have not seen similar differences in the 
group.bmj.com on December 27, 2017 - Published by http://openheart.bmj.com/Downloaded from 
5Radovanovic D, et al. Open Heart 2017;4:e000689. doi:10.1136/openhrt-2017-000689
Coronary artery disease
Swiss population. Further studies are therefore needed in 
order to be able to explain these differences.
Throughout the entire observational period in our 
study, women were overall less likely to received guide-
line-recommended drugs, which is in line with other 
publications.36 This is in contrast to the findings of the 
‘Acute Coronary Treatment and Intervention Outcomes 
Network Registry—Get with the Guidelines’ study of 
75 370 patients with STEMI and NSTEMI enrolled from 
July 2008 to March 2011 where acute and discharge 
medical therapies were similar by race in any gender 
category.37 In patients with NSTEMI, gender-based 
differences in adverse outcomes persisted even with an 
increased rate of early invasive therapy.38 As the strategy 
of an early invasive approach for women with NSTEMI 
was considered controversial in the 2000s, we decided 
against analysing this particular point.
limitations of the study
The limitations of the study are those common to all 
observational studies, particularly long-lasting studies 
over decades. The diagnosis of AMI has been repeatedly 
updated during the last 20 years, and the introduction 
of new biomarkers has resulted in more patients being 
diagnosed with AMI, particularly patients with NSTEMI, 
which is a non-calculated bias. Furthermore, the choice 
of intervention and medication was at the discretion of 
the treating physicians or internal hospital guidelines, 
which could also cause an unknown bias. However, data 
from ‘real-life’ routine clinical practice, which includes 
patients who were polymorbid, who were late comers or 
who were treated palliative only, contribute to a better 
estimation of the overall burden of AMI.
COnClusIOns
From 1997 to 2016, in-hospital mortality of patients with 
AMI in Switzerland has halved and the gender gap was 
further reduced. Accordingly, the mortality reduction 
was more pronounced in women, especially those in 
the age category below 60 years. The mortality decrease 
could in large be explained by the increase in the use 
of reperfusion therapy, in particular PCI, whereby the 
gender difference disappeared.
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